http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2837877-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a32039cd71ddd00941ff6cbeeb2bb03
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
filingDate 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f58d329e7752a1a8be6ce45e22a828e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef58188343f003d27a25471d43d848ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79945105c97573e01be6409ed2cad983
publicationDate 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2837877-A1
titleOfInvention GALENIC COMPOSITION, FOR ORAL USE, LIQUID, INCLUDING MELATONIN AND A ZINC SALT AND CORRESPONDING METHOD AND USE
abstract Galenic composition, for oral, liquid use, comprising melatonin and a zinc salt and corresponding method and use. Liquid galenic composition, for oral use, comprising between 0.4% and 0.6% by weight, with respect to the total weight of the composition, of melatonin and between 0.8% and 1.1% by weight of zinc, relative to the total weight of the composition, of a zinc salt. A method for its preparation comprises the steps of: (a) incorporating and dissolving the zinc salt in water; (b) incorporation of glycerin in the solution obtained in (a); (c) dissolving the melatonin in ethyl alcohol; and (d) incorporation of the solution obtained in (c) in the solution obtained in (b). The composition is preferably used as a liquid oral galenic preparation for the treatment of sleep disturbances and mood states.
priorityDate 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003165439-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013273176-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015125548-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012140333-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015044968-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016166543-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019038586-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014302170-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452427411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409954527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449316130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13355

Total number of triples: 56.